Vistagen Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q2 2011 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Vistagen Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2011 to Q3 2024.
  • Vistagen Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending November 6, 2024 was 27.8M shares, a 3.04% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 27.8M +820K +3.04% Nov 6, 2024 10-Q 2024-11-07
Q2 2024 27M +19.2M +243% Jun 7, 2024 10-K 2024-06-11
Q4 2023 27M -192M -87.7% Feb 12, 2024 10-Q 2024-02-13
Q3 2023 27M -180M -86.9% Nov 9, 2023 10-Q 2023-11-09
Q2 2023 7.87M -199M -96.2% Jun 22, 2023 10-K 2023-06-28
Q4 2022 219M +12.8M +6.2% Feb 7, 2023 10-Q 2023-02-07
Q3 2022 207M +7.13M +3.57% Nov 9, 2022 10-Q 2022-11-10
Q2 2022 207M +15.3M +7.97% Jun 22, 2022 10-K 2022-06-23
Q4 2021 207M +64.8M +45.8% Feb 9, 2022 10-Q 2022-02-10
Q3 2021 200M +126M +170% Nov 9, 2021 10-Q 2021-11-10
Q2 2021 191M +136M +243% Jun 28, 2021 10-K 2021-06-29
Q4 2020 142M +93.7M +195% Feb 11, 2021 10-Q 2021-02-11
Q3 2020 74M +30.8M +71.2% Nov 12, 2020 10-Q 2020-11-12
Q2 2020 55.8M +13.2M +30.9% Jun 26, 2020 10-K 2020-06-30
Q4 2019 48M +16.8M +54.1% Feb 11, 2020 10-Q 2020-02-13
Q3 2019 43.2M +12.2M +39.2% Nov 6, 2019 10-Q 2019-11-07
Q2 2019 42.6M +19.6M +85% Jun 21, 2019 10-K 2019-06-25
Q4 2018 31.1M +8.22M +35.9% Feb 11, 2019 10-Q 2019-02-12
Q3 2018 31.1M +19.4M +165% Oct 26, 2018 10-Q 2018-10-29
Q2 2018 23M +13.7M +148% Jun 25, 2018 10-K 2018-06-26
Q4 2017 22.9M +14.3M +167% Feb 9, 2018 10-Q 2018-02-12
Q3 2017 11.7M +3.32M +39.6% Nov 9, 2017 10-Q 2017-11-09
Q2 2017 9.3M +1.33M +16.7% Jun 27, 2017 10-K 2017-06-29
Q4 2016 8.58M +6.31M +278% Feb 10, 2017 10-Q 2017-02-13
Q3 2016 8.38M +6.63M +379% Nov 11, 2016 10-Q 2016-11-15
Q2 2016 7.97M +6.38M +400% Jun 22, 2016 10-K 2016-06-24
Q4 2015 2.27M +799K +54.2% Feb 12, 2016 10-Q 2016-02-16
Q3 2015 1.75M Nov 13, 2015 10-Q 2015-11-16
Q2 2015 1.59M -23.9M -93.7% Jun 25, 2015 10-K 2015-06-29
Q4 2014 1.47M -21.9M -93.7% Feb 13, 2015 10-Q 2015-02-17
Q2 2014 25.5M +4.19M +19.7% Jun 19, 2014 10-K 2014-06-25
Q4 2013 23.4M +3.27M +16.3% Feb 10, 2014 10-Q 2014-02-14
Q3 2013 22.2M +4.84M +27.9% Nov 12, 2013 10-Q 2013-11-14
Q2 2013 21.3M +3.71M +21.1% Jul 12, 2013 10-K 2013-07-18
Q4 2012 20.1M +3.59M +21.7% Feb 12, 2013 10-Q 2013-02-14
Q3 2012 17.3M +2.1M +13.8% Nov 12, 2012 10-Q 2012-11-14
Q2 2012 17.6M +2.32M +15.2% Jun 28, 2012 10-K 2012-07-02
Q4 2011 16.5M Feb 13, 2012 10-Q 2012-02-14
Q3 2011 15.2M Sep 30, 2011 10-Q 2011-11-14
Q2 2011 15.2M Jun 30, 2011 10-Q 2011-08-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.